| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |